Incruse Ellipta - Umeclidinium
GSK
Description
Antimuscarinic bronchodilator.
• Over 18 years for COPD: by inhalation of powder, 55 mcg (1 inhalation), once daily.
Indications
For the maintenance treatment of COPD.
Contraindications
Not recommended in the case of hepatic impairment, pregnancy or breast feeding.
Preparations Available
Inhalation powder
Sizes Available
Inhalation powder
Incruse Ellipta 55 mcg/dose, 30 doses
More on: Bronchodilators , Antimuscarinic bronchodilators